Arrowhead Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Sep2010 Sep2011 Sep2012 Sep2013 Sep2014 Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Operating Activities
Net Income -2.65M5.29M-0.00M-0.00M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Depreciation and Depletion 1.55M2.99M3.00M
Share-based Compensation 1.42M43.00M1.24M1.54M5.70M10.23M11.60M7.89M8.45M12.39M43.38M76.67M120.89M78.13M73.97M63.37M
Cash from Discontinued Operations -2.65M2.27M-0.00M-0.00M
Gains from Sales and Divestitures 0.28M0.42M0.79M1.33M2.20M1.16M0.90M
Gains from Investment Securities 0.22M0.73M1.91M3.42M3.85M5.44M6.69M5.55M5.52M4.77M4.54M3.46M-4.43M-3.74M0.81M
Asset Writedowns and Impairment 2.17M2.05M
Non-cash Items 1.31M1.68M2.68M12.79M3.39M4.00M3.52M2.92M2.51M
Cash from Operations -5.05M-7.66M-15.34M-19.03M-35.42M-65.71M-64.43M-23.94M-47.22M173.03M-95.80M171.31M-136.13M-153.89M-462.85M179.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M0.01M0.13M0.79M-1.11M-0.23M0.04M-0.38M-1.07M-0.53M-0.27M-2.91M2.02M3.24M5.79M
Amortization of Deferred Charges 9.32M63.33M
Depreciation & Amortization (CF) 0.28M0.27M1.75M1.75M1.35M2.34M3.26M4.69M4.70M4.44M5.94M8.27M10.42M12.49M18.59M23.93M
Change in Working Capital
Change in Receivables 0.87M0.74M0.94M0.07M-0.07M0.79M0.07M-0.01M0.26M0.33M0.18M9.41M-8.85M-1.41M56.97M
Change in Account Payables -0.20M0.16M0.29M0.32M1.41M2.50M2.55M-3.51M-1.27M4.84M-0.82M2.63M-6.59M33.00M-5.54M6.29M
Change in Accured Expenses 0.11M0.45M0.88M-0.19M3.48M4.44M-0.87M-0.40M1.02M2.45M1.99M9.52M17.75M-14.96M32.12M41.50M
Other Working Capital Changes 0.11M0.10M0.04M-0.04M0.15M0.12M0.11M1.64M0.24M0.09M0.07M0.22M-112.50M-129.18M2.24M9.94M
Investing Activities
Capital Expenditures 0.01M0.48M0.30M1.72M10.00M3.86M7.92M1.42M12.00M11.95M23.57M52.78M176.74M141.47M22.70M
Sales of Property, Plant and Equipment 0.29M0.09M0.01M0.00M
Divestments 0.49M
Change in Acquisitions & Divestments 1.53M0.51M1.42M11.59M26.09M17.31M4.25M46.07M54.52M50.14M122.59M270.75M326.72M442.34M689.63M
Cash from Investing Activities -0.18M0.44M-9.52M-36.48M14.12M13.45M-48.64M-7.43M-47.75M-240.78M-141.68M-5.42M-96.16M-420.07M-129.29M
Financing Activities
Other financing activities -0.13M3.13M5.00M
Cash from Financing Activities 12.17M6.23M10.77M44.29M185.29M0.29M55.13M12.06M59.95M66.38M257.95M11.30M65.19M253.05M870.52M74.01M
Additional items
Exchange Rate Effect 0.41M-0.09M-0.07M-0.12M4.20M-0.40M
Change in Cash 4.83M0.66M-4.13M15.74M113.40M-51.30M4.15M-60.53M5.29M191.67M-78.63M40.94M-76.36M3.01M-12.40M124.26M
Free Cash Flow -5.05M-7.67M-15.82M-19.33M-37.13M-75.71M-68.29M-31.86M-48.64M161.03M-107.75M147.75M-188.91M-330.63M-604.32M156.85M
Net Cash Flow 7.11M-1.61M-4.13M15.74M113.40M-51.30M4.15M-60.53M5.29M191.67M-78.63M40.94M-76.36M3.01M-12.40M124.26M